Talk to us
Regulatory Services
Slide background
Slide background
Slide background
Slide background
Slide background

Regulatory Services (ANDAs)

Regulatory Affairs

Piramal Corporate Regulatory Affairs, located in Mumbai, India provides expert clinical & regulatory support in all phases of global drug development programs. This includes regulatory support of New Chemical Entity’s development (NCE), Clinical Trials, Marketing products, Generics, OTC products & Medical devices

Below mentioned are detailed features of our services that we offer of different type of customers

Finished Formulations

  • Filing of NDA / ANDAs In USA, Europe, Canada, Asia Pacific and semi-regulated countries.
  • Experience in regulatory filing of dosage forms including Immediate / Modified released solid dosage forms, parenterals (liquid, powder for injection), Nasal spray etc.
  • ANDA / Generic Application with Paragraph II, III and IV certifications
  • Experiecne in ‘Firt to File’ generic applications
  • Experince in 505 (b) (2) application in the US
  • Support Innovator Companies to writing SNDA / NDA’s (CMC Section-Module 1, 2 &3)
  • Experience of review and compilation of Toxicology, Pharmacology and Clinical Sections (Module 4 &5)
  • CTD / eCTD submissions with MRPs & DCP procedures in Europe.
  • Post apporval maintenance – submission of PAS, CBE 30/CBE, Annual Reports to US, Vairations to EU.
  • Electroninc Site registrations, GDUFA obligations like site identifications, Drug listing and SPL support for labeling for US.
  • Vitamin dossiers supporting to food industry including food facility registation to US

IND / Clinical Trial Application

  • IND expertise in compilation of CMC, pre-clinical and clinical review including regulatory development strategy.
  • IND filing experience in US, Europe (France, Hungary, Czech, Netherlands), Australia, New Zealand, Argentina and India
  • Total INDs filed by Piramal-38 No’s
    • Phase I-19 No’s,
    • Phase II-15 No’s,
    • Phase III-3 No’s
    • Phase IV-1 No.
  • CTA (in Phase I and Phase II and III) filed in various countries in Europe, Canada, US and India.
  • Three Herbal products are in phase-II / III clinical trial
  • For clients (INDs filed by client) – JV with clients complete IND filing for co-development
    • Phase I- 5 No’s
    • Phase II- 2 No’s

Active Pharmaceutical Ingredients

  • Experienced in filing DMF’s and CEP’s / COS
  • About 40 DMF’s and COS submitted in USA and Europe for supplying APIs to regulated markets
  • Active DMFS in USA, Europe, Canada, Asia Pacific and semi-regulated countries (as applicable).
  • CTD/eCTD submissions successfully done for EU,US, ROW countries.